Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Dyadic International Inc. stock logo
DYAI
Dyadic International
$0.98
-0.5%
$0.99
$0.91
$2.20
$29.50M0.8854,169 shs27,984 shs
Cue Health Inc. stock logo
HLTH
Cue Health
$0.04
-29.8%
$0.07
$0.04
$0.74
$6.91M1.0913.38 million shs96.00 million shs
Rafael Holdings, Inc. stock logo
RFL
Rafael
$2.15
-2.5%
$1.71
$1.28
$3.19
$77.20M0.9793,926 shs96,205 shs
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$4.33
+3.1%
$4.72
$4.01
$9.33
$69.07M1.29187,987 shs69,063 shs
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Dyadic International Inc. stock logo
DYAI
Dyadic International
-0.53%+1.56%+4.84%-20.73%-35.86%
Cue Health Inc. stock logo
HLTH
Cue Health
0.00%0.00%0.00%0.00%0.00%
Rafael Holdings, Inc. stock logo
RFL
Rafael
-2.72%+12.89%+8.33%+28.44%+55.43%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
+3.10%-5.66%-10.17%-5.66%-27.71%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Dyadic International Inc. stock logo
DYAI
Dyadic International
3.1432 of 5 stars
3.55.00.00.03.31.70.0
Cue Health Inc. stock logo
HLTH
Cue Health
N/AN/AN/AN/AN/AN/AN/AN/A
Rafael Holdings, Inc. stock logo
RFL
Rafael
1.5305 of 5 stars
0.05.00.00.01.62.50.6
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
1.0625 of 5 stars
3.50.00.00.02.20.00.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Dyadic International Inc. stock logo
DYAI
Dyadic International
3.00
Buy$6.00515.38% Upside
Cue Health Inc. stock logo
HLTH
Cue Health
0.00
N/AN/AN/A
Rafael Holdings, Inc. stock logo
RFL
Rafael
0.00
N/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
3.00
Buy$11.67169.44% Upside

Current Analyst Ratings Breakdown

Latest RFL, SRTS, HLTH, and DYAI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/19/2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$14.00 ➝ $10.00
(Data available from 7/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Dyadic International Inc. stock logo
DYAI
Dyadic International
$3.49M8.41N/AN/A$0.08 per share12.19
Cue Health Inc. stock logo
HLTH
Cue Health
$70.94M0.10N/AN/A$1.62 per share0.03
Rafael Holdings, Inc. stock logo
RFL
Rafael
$732K102.83N/AN/A$3.51 per share0.61
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$41.81M1.70$0.45 per share9.72$3.41 per share1.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Dyadic International Inc. stock logo
DYAI
Dyadic International
-$5.81M-$0.20N/AN/AN/A-163.94%-233.69%-59.37%8/12/2025 (Estimated)
Cue Health Inc. stock logo
HLTH
Cue Health
-$373.46M-$2.44N/AN/AN/A-526.48%-67.82%-53.79%N/A
Rafael Holdings, Inc. stock logo
RFL
Rafael
-$34.41M-$0.94N/AN/A-3,127.60%-24.75%-21.12%N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$6.65M$0.1043.3018.83N/A4.56%3.34%3.00%8/6/2025 (Estimated)

Latest RFL, SRTS, HLTH, and DYAI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025N/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.01N/AN/AN/A$9.30 millionN/A
8/12/2025Q2 2025
Dyadic International Inc. stock logo
DYAI
Dyadic International
-$0.06N/AN/AN/A$0.60 millionN/A
6/11/2025Q3 2025
Rafael Holdings, Inc. stock logo
RFL
Rafael
N/A-$0.19N/A-$0.19N/A$0.36 million
5/15/2025Q1 2025
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
$0.04-$0.16-$0.20-$0.16$7.23 million$8.34 million
5/14/2025Q1 2025
Dyadic International Inc. stock logo
DYAI
Dyadic International
N/A-$0.07N/A-$0.07N/A$0.39 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Dyadic International Inc. stock logo
DYAI
Dyadic International
N/AN/AN/AN/AN/A
Cue Health Inc. stock logo
HLTH
Cue Health
N/AN/AN/AN/AN/A
Rafael Holdings, Inc. stock logo
RFL
Rafael
N/AN/AN/AN/AN/A
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Dyadic International Inc. stock logo
DYAI
Dyadic International
5.40
3.98
3.98
Cue Health Inc. stock logo
HLTH
Cue Health
N/A
2.54
2.22
Rafael Holdings, Inc. stock logo
RFL
Rafael
N/A
3.85
3.82
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
N/A
8.06
5.74

Institutional Ownership

CompanyInstitutional Ownership
Dyadic International Inc. stock logo
DYAI
Dyadic International
27.95%
Cue Health Inc. stock logo
HLTH
Cue Health
45.49%
Rafael Holdings, Inc. stock logo
RFL
Rafael
11.30%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
25.30%

Insider Ownership

CompanyInsider Ownership
Dyadic International Inc. stock logo
DYAI
Dyadic International
29.50%
Cue Health Inc. stock logo
HLTH
Cue Health
12.50%
Rafael Holdings, Inc. stock logo
RFL
Rafael
10.20%
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
8.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Dyadic International Inc. stock logo
DYAI
Dyadic International
730.09 million21.21 millionOptionable
Cue Health Inc. stock logo
HLTH
Cue Health
726159.09 million139.21 millionOptionable
Rafael Holdings, Inc. stock logo
RFL
Rafael
2035.09 million31.51 millionOptionable
Sensus Healthcare, Inc. stock logo
SRTS
Sensus Healthcare
4016.44 million14.98 millionOptionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Dyadic International stock logo

Dyadic International NASDAQ:DYAI

$0.98 -0.01 (-0.53%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$1.02 +0.04 (+4.41%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States and internationally. It utilizes C1-cell protein production platform based on an industrially proven microorganism (C1) for the development and production of biologic products including enzymes and other proteins for human and animal health. The company offers DYAI-100, SARS-CoV-2-RBD antigen vaccine candidate towards a first-in-human Phase 1 clinical trial to demonstrate the safety in humans of a protein produced using the C1 platform. It has also developed the Dapibus thermophilic, a filamentous fungal-based microbial protein production platform to enable the development and large-scale manufacture of cost-effective proteins, metabolites, and other biologic products for use in non-pharmaceutical applications, including food, nutrition, and wellness. The company has a research and development agreement with VTT Technical Research Centre of Finland, Ltd.; license agreement with South Africa's Rubic One Health; Joint Development Agreement with a Global Food Ingredient Company; and sub-license agreement with Abic Biological Laboratories Ltd., Alphazyme, LLC, and Abic Biological Laboratories Ltd. Dyadic International, Inc. was founded in 1979 and is headquartered in Jupiter, Florida.

Cue Health stock logo

Cue Health NASDAQ:HLTH

Cue Health Inc. operates as a healthcare technology company. It provides the Cue Health platform that offers individuals and healthcare providers convenient and personalized access to lab-quality diagnostic tests at home and at the point-of-care, as well as on-demand telehealth consultations and treatment options for a range of health and wellness needs. It offers Cue Integrated Care platform comprising hardware, software, and diagnostic components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, including integration with electronic medical record system, pharmacies and last-mile delivery, clinician networks, and laboratories. The company also provides COVID-19 testing kits. The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017. Cue Health Inc. was incorporated in 2010 and is headquartered in San Diego, California.

Rafael stock logo

Rafael NYSE:RFL

$2.14 -0.06 (-2.50%)
Closing price 07/16/2025 03:59 PM Eastern
Extended Trading
$2.12 -0.02 (-1.17%)
As of 07:06 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rafael Holdings, Inc. primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. It operates in two segments, Healthcare and Real Estate. The company engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Its lead drug candidate is CPI-613 (devimistat), currently under Phase III clinical study for the treatment of metastatic pancreatic cancer and acute myeloid leukemia. The company is also involved in developing Promitil, a molecule designed for the targeted delivery of mitomycin-C in a proprietary prodrug form, completed Phase 1B clinical studies; Folate-targeted Promitil (Promi-Fol) which is aimed at local treatment (intravesical) of superficial bladder cancer; and Promi-Dox, a highly potent dual drug liposome with MLP and doxorubicin targeting a potential basket of tumors. In addition, it engages in the development of surgical and procedural devices, including orthopedic arthroscopy instrumentation. Rafael Holdings, Inc. was incorporated in 2017 and is headquartered in Newark, New Jersey.

Sensus Healthcare stock logo

Sensus Healthcare NASDAQ:SRTS

$4.33 +0.13 (+3.10%)
Closing price 07/16/2025 04:00 PM Eastern
Extended Trading
$4.40 +0.07 (+1.62%)
As of 07:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.